Tesamorelin Pen 20mg research peptideBest Seller
Growth Hormone

Tesamorelin Pen 20mg

Pre-loaded Tesamorelin GHRH-analogue research pen. Investigated for its role in visceral-adipose-tissue research.

Purity

99%+

CAS Number

218949-48-5

Status

In Stock

Dispatch

Same-Day (before 2pm)

Select Size

£169.99

Research verification required. All orders are reviewed before dispatch. You will receive an email confirmation and a WhatsApp or phone call within 60 minutes to verify your research purpose.

Third-Party CoA Included Free Delivery Over £75 Research Use Only

About Tesamorelin Pen 20mg

Tesamorelin is a stabilised synthetic growth-hormone-releasing-hormone (GHRH) analogue (44 amino acids) studied for its activity at the GHRH receptor and downstream effects on endogenous GH/IGF-1 axis signalling. Preclinical and clinical research has focused specifically on its role in visceral adipose tissue investigation rather than general weight loss. Supplied as a pre-loaded research pen for in-vitro and preclinical applications.

Research Applications

Research Mechanism — Tesamorelin Pen 20mg

A simplified summary of what Tesamorelin Pen 20mg is studied for in research models. For laboratory in-vitro use only.

Sequence:trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu

Origin: Synthetic 44-residue stabilised analogue of human growth hormone-releasing hormone (GHRH 1-44), with an N-terminal hexenoyl modification for protease resistance.

  1. Molecular target

    A stabilised GHRH analogue investigated for its binding to pituitary somatotroph receptors and its activation of cAMP-coupled signalling in research models.

    • Growth hormone-releasing hormone receptor (GHRH-R)
    • Gαs-coupled adenylyl cyclase complex
    • Pit-1 transcription factor regulatory axis

  2. Investigated pathways

    Preclinical studies have explored downstream effects on cAMP–PKA signalling, somatotroph gene expression, and IGF-1 axis responses in cultured pituitary cells.

    • cAMP–PKA–CREB signalling cascade
    • Somatotroph GH gene-expression assays
    • Hepatic IGF-1 transcriptional response

  3. Preclinical research applications

    Used as a research tool in laboratory models exploring pituitary endocrinology, lipid-metabolism science, and visceral-adipose research. Not approved for human use.

    • Somatotroph cell-line GH secretion assays
    • Visceral adipocyte lipolysis models
    • GH–IGF-1 axis preclinical studies

For research use only. Tesamorelin Pen 20mg is not approved as a medicine in the UK and is not intended for human or veterinary administration. See the compliance page for full terms.

Technical Specifications

Compound NameTesamorelin Pen 20mg
CategoryGrowth Hormone
CAS Number218949-48-5
Molecular Weight5135.79 g/mol
Molecular FormulaC₂₂₁H₃₆₆N₇₂O₆₇S
Sequence44-amino-acid GHRH analogue with N-terminal hexenoyl modification
Purity≥99%+ (HPLC)
FormLyophilised powder
StorageStore at 2–8°C. Protect from light. Use within 30 days of opening.
ReconstitutionPre-formulated in solution; no reconstitution required.

Certificate of Analysis

Every order of Tesamorelin Pen 20mg includes a batch-specific CoA with HPLC chromatogram, mass spectrometry data, and laboratory accreditation details.

View Sample CoA

Tesamorelin Pen 20mg — Frequently Asked Questions

What is Tesamorelin?

A 44-amino-acid synthetic GHRH analogue investigated for its role in growth-hormone axis research and visceral adipose tissue science.

What purity is your Tesamorelin pen?

99%+, confirmed by independent third-party HPLC analysis. Batch-specific CoA included.

Is Tesamorelin approved for human use?

No. Supplied for in-vitro laboratory research only. Tesamorelin is still experimental and not recommended for human consumption.

📊Certificates of Analysis🔬Quality & Testing📋Research Guidelines⚖️UK Compliance

Tesamorelin Pen 20mg is supplied by Premio Peptides (BELL RED LIMITED) exclusively for in vitro laboratory research. It is not a licensed medicine, is not approved for human or veterinary use, and must not be administered to any living organism outside a formally approved research protocol. Purchasers assume full responsibility for compliance with applicable regulations.

Related Compounds

BPC-157 research peptide
Healing & Recovery

BPC-157

£130.00View →
TB-500 research peptide
Healing & Recovery

TB-500

£199.99View →
CJC-1295 No DAC research peptide
Growth Hormone

CJC-1295 No DAC

£199.99View →